Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals (formerly Microbia) is a drug developer that is busy testing the gastrointestinal drug candidates in its pipeline. The company is developing lead drug candidate linaclotide, which is undergoing trials in partnership with Forest Laboratories and other co-developers for the treatment of irritable bowel syndrome, abdominal pain, and chronic constipation. The company's Microbia biotechnology subsidiary harnesses microbes to produce specialty chemicals from renewable resources with applications the agriculture, chemical, and pharmaceutical industries. Ironwood Pharmaceuticals made a move to go public when it filed for an IPO in 2009.

Contact Details

Office Address

Ironwood Pharmaceuticals, Inc.
320 Bent Street, 4th floor
Cambridge, MA, USA 02141
Phone: (617) 621-7722
Fax: (617) 494-0908

Executives

Chairman

Joseph C. Cook Jr.

CEO and Director

Peter M. Hecht

Business Reviews for Ironwood Pharmaceuticals, Inc.

Related Companies